← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aradigm Corporation
Hayward, CA
$1,743,392
Total funding
4
Grants
Funding over time
peak $617.6K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,743,392 · 4
By mechanism
R44$972,649 · 1
R43$770,743 · 3
Investigators at Aradigm Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
In vitro and in vivo efficacy of liposomal ciprofloxacin formulations against Mycobacterium avium and Mycobacterium abscessus$486,599
R44 · FY2017 · AI
In vitro and in vivo efficacy of liposomal ciprofloxacin formulations against Mycobacterium avium and Mycobacterium abscessus$486,050
R44 · FY2018 · AI
Development and Validation of test for Gastro-esophageal Reflux with Aspiration$339,824
R43 · FY2013 · HL
In vitro and in vivo efficacy of liposomal ciprofloxacin formulations against Myc$277,768
R43 · FY2013 · AI
Pulmonary delivery of nicotine using the AERx System$153,151
R43 · FY2005 · DA